Paul Hargreaves
Corporate Officer/Principal chez SPAGO NANOMEDICAL AB
Profil
Paul Hargreaves is currently the Chief Development Officer at Spago Nanomedical AB since 2021.
Prior to this, he worked at LEO Pharma.
A as the Head-Global Clinical Operations & Vice President.
Postes actifs de Paul Hargreaves
| Sociétés | Poste | Début |
|---|---|---|
| SPAGO NANOMEDICAL AB | Corporate Officer/Principal | 13/09/2021 |
Anciens postes connus de Paul Hargreaves
| Sociétés | Poste | Fin |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPAGO NANOMEDICAL AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
